Johnson Health Tech Co Ltd (1736) - Net Assets
Based on the latest financial reports, Johnson Health Tech Co Ltd (1736) has net assets worth NT$14.09 Billion TWD (≈ $443.93 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$46.41 Billion ≈ $1.46 Billion USD) and total liabilities (NT$32.32 Billion ≈ $1.02 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Johnson Health Tech Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$14.09 Billion |
| % of Total Assets | 30.36% |
| Annual Growth Rate | 10.46% |
| 5-Year Change | 46.44% |
| 10-Year Change | 59.64% |
| Growth Volatility | 16.51 |
Johnson Health Tech Co Ltd - Net Assets Trend (2002–2025)
This chart illustrates how Johnson Health Tech Co Ltd's net assets have evolved over time, based on quarterly financial data. See Johnson Health Tech Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Johnson Health Tech Co Ltd (2002–2025)
The table below shows the annual net assets of Johnson Health Tech Co Ltd from 2002 to 2025. For live valuation and market cap data, see Johnson Health Tech Co Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$13.74 Billion ≈ $432.81 Million |
+14.06% |
| 2024-12-31 | NT$12.04 Billion ≈ $379.47 Million |
+24.82% |
| 2023-12-31 | NT$9.65 Billion ≈ $304.01 Million |
+1.76% |
| 2022-12-31 | NT$9.48 Billion ≈ $298.74 Million |
+1.08% |
| 2021-12-31 | NT$9.38 Billion ≈ $295.56 Million |
-8.76% |
| 2020-12-31 | NT$10.28 Billion ≈ $323.93 Million |
+12.53% |
| 2019-12-31 | NT$9.14 Billion ≈ $287.87 Million |
+8.38% |
| 2018-12-31 | NT$8.43 Billion ≈ $265.61 Million |
+3.22% |
| 2017-12-31 | NT$8.17 Billion ≈ $257.32 Million |
-5.09% |
| 2016-12-31 | NT$8.61 Billion ≈ $271.12 Million |
-3.42% |
| 2015-12-31 | NT$8.91 Billion ≈ $280.71 Million |
-2.09% |
| 2014-12-31 | NT$9.10 Billion ≈ $286.71 Million |
+35.61% |
| 2013-12-31 | NT$6.71 Billion ≈ $211.43 Million |
+13.95% |
| 2012-12-31 | NT$5.89 Billion ≈ $185.55 Million |
+4.98% |
| 2011-12-31 | NT$5.61 Billion ≈ $176.74 Million |
+19.53% |
| 2010-12-31 | NT$4.69 Billion ≈ $147.86 Million |
-2.70% |
| 2009-12-31 | NT$4.82 Billion ≈ $151.96 Million |
-4.19% |
| 2008-12-31 | NT$5.03 Billion ≈ $158.61 Million |
-3.91% |
| 2007-12-31 | NT$5.24 Billion ≈ $165.06 Million |
+1.64% |
| 2006-12-31 | NT$5.15 Billion ≈ $162.40 Million |
+43.35% |
| 2005-12-31 | NT$3.60 Billion ≈ $113.29 Million |
+48.91% |
| 2004-12-31 | NT$2.41 Billion ≈ $76.08 Million |
+29.43% |
| 2003-12-31 | NT$1.87 Billion ≈ $58.78 Million |
+33.85% |
| 2002-12-31 | NT$1.39 Billion ≈ $43.91 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Johnson Health Tech Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1377.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$8.61 Billion | 62.74% |
| Common Stock | NT$3.03 Billion | 22.10% |
| Other Comprehensive Income | NT$2.03 Billion | 14.77% |
| Other Components | NT$54.77 Million | 0.40% |
| Total Equity | NT$13.73 Billion | 100.00% |
Johnson Health Tech Co Ltd Competitors by Market Cap
The table below lists competitors of Johnson Health Tech Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orezone Gold Corp
TO:ORE
|
$1.14 Billion |
|
Liquidity Services Inc
NASDAQ:LQDT
|
$1.14 Billion |
|
Ficont Industry (Beijing) Co. Ltd.
SHG:605305
|
$1.14 Billion |
|
Ambea AB
ST:AMBEA
|
$1.14 Billion |
|
Petkim Petrokimya Holding AS
IS:PETKM
|
$1.14 Billion |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
$1.14 Billion |
|
thyssenkrupp nucera AG & Co. KGaA
XETRA:NCH2
|
$1.14 Billion |
|
Shijiazhuang Kelin Elec Co
SHG:603050
|
$1.14 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Johnson Health Tech Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,037,344,000 to 13,729,588,000, a change of 1,692,244,000 (14.1%).
- Net income of 2,750,086,000 contributed positively to equity growth.
- Dividend payments of 1,213,578,000 reduced retained earnings.
- New share issuances of 5,780,000 increased equity.
- Other comprehensive income increased equity by 3,777,623,000.
- Other factors decreased equity by 3,627,667,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$2.75 Billion | +20.03% |
| Dividends Paid | NT$1.21 Billion | -8.84% |
| Share Issuances | NT$5.78 Million | +0.04% |
| Other Comprehensive Income | NT$3.78 Billion | +27.51% |
| Other Changes | NT$-3.63 Billion | -26.42% |
| Total Change | NT$- | 14.06% |
Book Value vs Market Value Analysis
This analysis compares Johnson Health Tech Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.64x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7.19x to 2.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | NT$16.62 | NT$119.50 | x |
| 2007-12-31 | NT$17.09 | NT$119.50 | x |
| 2008-12-31 | NT$16.53 | NT$119.50 | x |
| 2009-12-31 | NT$15.82 | NT$119.50 | x |
| 2010-12-31 | NT$15.43 | NT$119.50 | x |
| 2011-12-31 | NT$18.45 | NT$119.50 | x |
| 2012-12-31 | NT$19.36 | NT$119.50 | x |
| 2013-12-31 | NT$22.08 | NT$119.50 | x |
| 2014-12-31 | NT$29.92 | NT$119.50 | x |
| 2015-12-31 | NT$29.28 | NT$119.50 | x |
| 2016-12-31 | NT$28.33 | NT$119.50 | x |
| 2017-12-31 | NT$26.93 | NT$119.50 | x |
| 2018-12-31 | NT$27.79 | NT$119.50 | x |
| 2019-12-31 | NT$30.11 | NT$119.50 | x |
| 2020-12-31 | NT$30.88 | NT$119.50 | x |
| 2021-12-31 | NT$28.02 | NT$119.50 | x |
| 2022-12-31 | NT$31.31 | NT$119.50 | x |
| 2023-12-31 | NT$31.83 | NT$119.50 | x |
| 2024-12-31 | NT$39.69 | NT$119.50 | x |
| 2025-12-31 | NT$45.23 | NT$119.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Johnson Health Tech Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.03%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.06%
- • Asset Turnover: 1.08x
- • Equity Multiplier: 3.65x
- Recent ROE (20.03%) is above the historical average (14.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 32.86% | 12.49% | 1.02x | 2.57x | NT$318.57 Million |
| 2003 | 30.80% | 11.80% | 1.08x | 2.42x | NT$387.98 Million |
| 2004 | 31.37% | 11.30% | 1.20x | 2.31x | NT$516.03 Million |
| 2005 | 34.31% | 14.45% | 1.21x | 1.96x | NT$874.24 Million |
| 2006 | 33.91% | 15.07% | 1.18x | 1.91x | NT$1.20 Billion |
| 2007 | 10.81% | 4.74% | 1.07x | 2.13x | NT$41.80 Million |
| 2008 | 0.05% | 0.02% | 1.10x | 2.18x | NT$-499.13 Million |
| 2009 | -1.37% | -0.65% | 0.97x | 2.18x | NT$-545.28 Million |
| 2010 | 5.35% | 2.13% | 1.13x | 2.21x | NT$-217.66 Million |
| 2011 | 13.76% | 5.65% | 1.06x | 2.30x | NT$210.69 Million |
| 2012 | 14.58% | 5.60% | 1.08x | 2.40x | NT$269.43 Million |
| 2013 | 12.78% | 5.69% | 1.02x | 2.21x | NT$186.23 Million |
| 2014 | 29.00% | 15.94% | 0.82x | 2.21x | NT$1.73 Billion |
| 2015 | 6.33% | 3.32% | 0.76x | 2.51x | NT$-326.94 Million |
| 2016 | 8.33% | 3.55% | 0.89x | 2.64x | NT$-143.91 Million |
| 2017 | 1.59% | 0.67% | 0.88x | 2.73x | NT$-686.05 Million |
| 2018 | 4.63% | 1.79% | 0.92x | 2.82x | NT$-452.68 Million |
| 2019 | 14.16% | 5.09% | 0.94x | 2.95x | NT$379.55 Million |
| 2020 | 7.27% | 2.39% | 0.91x | 3.34x | NT$-255.27 Million |
| 2021 | 1.17% | 0.32% | 0.87x | 4.16x | NT$-748.61 Million |
| 2022 | 2.37% | 0.67% | 0.86x | 4.10x | NT$-722.56 Million |
| 2023 | 7.36% | 1.86% | 1.05x | 3.78x | NT$-254.43 Million |
| 2024 | 20.19% | 5.09% | 1.10x | 3.62x | NT$1.23 Billion |
| 2025 | 20.03% | 5.06% | 1.08x | 3.65x | NT$1.38 Billion |
Industry Comparison
This section compares Johnson Health Tech Co Ltd's net assets metrics with peer companies in the Leisure industry.
Industry Context
- Industry: Leisure
- Average net assets among peers: $3,831,697,333
- Average return on equity (ROE) among peers: 6.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Johnson Health Tech Co Ltd (1736) | NT$14.09 Billion | 32.86% | 2.29x | $1.14 Billion |
| Trk Corp (1432) | $730.57 Million | -5.05% | 5.70x | $59.89 Million |
| Rexon Industrial Corp Ltd (1515) | $2.33 Billion | 4.56% | 1.33x | $148.08 Million |
| Sun Race Sturmey-Archer Inc (1526) | $1.00 Billion | 8.00% | 0.62x | $27.50 Million |
| Chi Hua Fitness Co Ltd (1593) | $898.86 Million | 13.38% | 0.22x | $38.17 Million |
| Dyaco International Inc (1598) | $4.87 Billion | 27.13% | 1.72x | $105.85 Million |
| Topkey Corp (4536) | $8.12 Billion | 27.82% | 1.00x | $466.40 Million |
| Brogent Technologies (5263) | $3.03 Billion | -4.35% | 0.57x | $226.59 Million |
| Janfusun Fancyworld (5701) | $1.07 Billion | -30.42% | 2.23x | $26.85 Million |
| Fusheng Precision Co Ltd (6670) | $12.43 Billion | 19.34% | 0.61x | $1.26 Billion |
About Johnson Health Tech Co Ltd
Johnson Health Tech .Co., Ltd., together with its subsidiaries, manufacturers and sells fitness equipment in the Americas, Europe, Asia, and internationally. The company offers cardiopulmonary resuscitation fitness machines, weight training machines, electric massage chairs and related motors, and instruments and electronic control panels, as well as instruments and electrical chairs, and related… Read more